Zoetis (ZTS) Other Non-Current Liabilities (2012 - 2026)

Zoetis (ZTS) reported Other Non-Current Liabilities of $281.0 million for Q1 2026, up 27.73% year-over-year from $220.0 million in Q1 2025, and up 1.81% quarter-over-quarter from $276.0 million in Q4 2025.

Zoetis (ZTS) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of Other Non-Current Liabilities data on file, last reported at $281.0 million in Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $281.0 million, up 27.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $281.0 million (up 27.73% YoY), and the FY2025 annual result was $276.0 million, up 24.32% from the prior year.
  • Other Non-Current Liabilities improved to $281.0 million in Q1 2026 per ZTS's latest filing, from $276.0 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $281.0 million in Q1 2026 and troughed at $216.0 million in Q1 2023.
  • A 5-year average of $251.2 million and a median of $258.0 million in 2022 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities gained 28.24% in 2024, then retreated 20.58% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $258.0 million in 2022, then climbed by 5.04% to $271.0 million in 2023, then dropped by 18.08% to $222.0 million in 2024, then grew by 24.32% to $276.0 million in 2025, then rose by 1.81% to $281.0 million in 2026.
  • Business Quant data shows ZTS's Other Non-Current Liabilities at $281.0 million in Q1 2026, $276.0 million in Q4 2025, and $264.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 281.00 Mn
Dec 31, 2025 276.00 Mn
Sep 30, 2025 264.00 Mn
Jun 30, 2025 274.00 Mn
Mar 31, 2025 220.00 Mn
Dec 31, 2024 222.00 Mn
Sep 30, 2024 220.00 Mn
Jun 30, 2024 222.00 Mn
Mar 31, 2024 277.00 Mn
Dec 31, 2023 271.00 Mn
Sep 30, 2023 259.00 Mn
Jun 30, 2023 278.00 Mn
Mar 31, 2023 216.00 Mn
Dec 31, 2022 258.00 Mn
Sep 30, 2022 241.00 Mn
Jun 30, 2022 250.00 Mn
Mar 31, 2022 241.00 Mn
Dec 31, 2021 257.00 Mn
Sep 30, 2021 259.00 Mn
Jun 30, 2021 261.00 Mn